Inflammatory Mediators and Clinical Outcome in Patients With Advanced Heart Failure Receiving Cardiac Resynchronization Therapy.

[1]  Jagmeet P. Singh,et al.  Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients , 2015, Pacing and clinical electrophysiology : PACE.

[2]  Amy D. Dobberfuhl,et al.  Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species. , 2013, Cellular signalling.

[3]  A. Karameris,et al.  Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis , 2013, BioMed research international.

[4]  Yan Du,et al.  TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway. , 2012, Frontiers in bioscience.

[5]  R. Schermuly,et al.  Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1β synthesis. , 2012, European heart journal.

[6]  D. Threadgill,et al.  EGFR signaling promotes TGFβ-dependent renal fibrosis. , 2012, Journal of the American Society of Nephrology : JASN.

[7]  L. Tao,et al.  Interleukin 6 Underlies Angiotensin II–Induced Hypertension and Chronic Renal Damage , 2012, Hypertension.

[8]  S. Zhuang,et al.  A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. , 2010, Kidney international.

[9]  Joshua M Hare,et al.  Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers. , 2010, European heart journal.

[10]  A. Shalaby,et al.  Usefulness of Brain Natriuretic Peptide Level at Implant in Predicting Mortality in Patients with Advanced But Stable Heart Failure Receiving Cardiac Resynchronization Therapy , 2009, Clinical cardiology.

[11]  D. Iliopoulos,et al.  Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment? , 2008, Expert opinion on therapeutic targets.

[12]  C. Hengstenberg,et al.  Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP. , 2007, Cytokine.

[13]  G. Fonarow,et al.  Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. , 2007, American Journal of Cardiology.

[14]  M. Ghazizadeh,et al.  Functional implications of the IL-6 signaling pathway in keloid pathogenesis. , 2007, The Journal of investigative dermatology.

[15]  Polly Matzinger,et al.  Friendly and dangerous signals: is the tissue in control? , 2007, Nature Immunology.

[16]  S. Mutsaers,et al.  Growth factors in pleural fibrosis , 2006, Current opinion in pulmonary medicine.

[17]  Christophe Leclercq,et al.  Cardiac resynchronization therapy: Part 1--issues before device implantation. , 2005, Journal of the American College of Cardiology.

[18]  M. Hetzel,et al.  Different Effects of Growth Factors on Proliferation and Matrix Production of Normal and Fibrotic Human Lung Fibroblasts , 2005, Lung.

[19]  F. Strutz,et al.  New insights into mechanisms of fibrosis in immune renal injury , 2003, Springer Seminars in Immunopathology.

[20]  E. Kardami,et al.  Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent. , 2002, American journal of physiology. Heart and circulatory physiology.

[21]  Michael J. Zilliox,et al.  Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. , 2001, The American journal of pathology.

[22]  H. Makino,et al.  Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium , 2001, Rheumatology International.

[23]  S. Opal,et al.  Anti-inflammatory cytokines. , 2000, Chest.

[24]  J. Fallon,et al.  Fibroblast growth factors as multifunctional signaling factors. , 1999, International review of cytology.

[25]  Keiichiro Suzuki,et al.  Interleukin 1α-induced expression of manganous superoxide dismutase reduces myocardial reperfusion injury in the rat , 1995 .